[HTML][HTML] Heart dose is an independent dosimetric predictor of overall survival in locally advanced non–small cell lung cancer
CK Speirs, TA DeWees, S Rehman… - Journal of Thoracic …, 2017 - Elsevier
Introduction In the randomized trial of standard-versus high-dose chemoradiotherapy for
locally advanced (LA) NSCLC (Radiation Therapy Oncology Group 0617), overall survival …
locally advanced (LA) NSCLC (Radiation Therapy Oncology Group 0617), overall survival …
[HTML][HTML] Stereotactic MR-guided online adaptive radiation therapy (SMART) for ultracentral thorax malignancies: results of a phase 1 trial
LE Henke, JR Olsen, JA Contreras, A Curcuru… - Advances in radiation …, 2019 - Elsevier
Purpose Stereotactic body radiation therapy (SBRT) is an effective treatment for
oligometastatic or unresectable primary malignancies, although target proximity to organs at …
oligometastatic or unresectable primary malignancies, although target proximity to organs at …
[HTML][HTML] Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non–small-cell lung cancer
CG Robinson, TA DeWees, IM El Naqa… - Journal of Thoracic …, 2013 - Elsevier
Introduction The purpose of this study was to compare patterns of failure between lobar
resection (lobectomy or pneumonectomy) and stereotactic body radiation therapy (SBRT) for …
resection (lobectomy or pneumonectomy) and stereotactic body radiation therapy (SBRT) for …
Clinical and dosimetric predictors of acute severe lymphopenia during radiation therapy and concurrent temozolomide for high-grade glioma
J Huang, TA DeWees, SN Badiyan, CK Speirs… - International Journal of …, 2015 - Elsevier
Purpose Acute severe lymphopenia (ASL) frequently develops during radiation therapy (RT)
and concurrent temozolomide (TMZ) for high-grade glioma (HGG) and is associated with …
and concurrent temozolomide (TMZ) for high-grade glioma (HGG) and is associated with …
A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy
J Huang, JL Campian, AD Gujar, DD Tran… - Journal of neuro …, 2016 - Springer
Disulfiram, a generic alcohol aversion drug, has promising preclinical activity against
glioblastoma (GBM). This phase I study aims to evaluate its safety, maximum tolerated dose …
glioblastoma (GBM). This phase I study aims to evaluate its safety, maximum tolerated dose …
Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of …
CR Spencer, HA Gay, BH Haughey, B Nussenbaum… - Cancer, 2014 - Wiley Online Library
BACKGROUND Radiation treatment volumes in head and neck squamous cell carcinoma
(HNSCC) are controversial. The authors report the outcomes, patterns of failure, and quality …
(HNSCC) are controversial. The authors report the outcomes, patterns of failure, and quality …
Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base
J Huang, P Samson, SM Perkins, G Ansstas… - Journal of neuro …, 2017 - Springer
To investigate the utilization and overall survival (OS) impact of concurrent chemotherapy in
combination with radiation therapy (RT) for elderly glioblastoma (GBM) patients. Elderly …
combination with radiation therapy (RT) for elderly glioblastoma (GBM) patients. Elderly …
[HTML][HTML] Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning
JJ Lucido, TA DeWees, TR Leavitt, A Anand… - Frontiers in …, 2023 - frontiersin.org
Introduction: Organ-at-risk segmentation for head and neck cancer radiation therapy is a
complex and time-consuming process (requiring up to 42 individual structure, and may …
complex and time-consuming process (requiring up to 42 individual structure, and may …
[HTML][HTML] Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells
Neurocognitive deficits are serious sequelae that follow cranial irradiation used to treat
patients with medulloblastoma and other brain neoplasms. Cranial irradiation causes …
patients with medulloblastoma and other brain neoplasms. Cranial irradiation causes …
[HTML][HTML] Stereotactic body radiation therapy for central early-stage NSCLC: results of a prospective phase I/II trial
MC Roach, CG Robinson, TA DeWees… - Journal of Thoracic …, 2018 - Elsevier
Introduction We report results from a prospective phase I/II trial for patients with centrally
located, early-stage NSCLC receiving stereotactic body radiation therapy. Methods Eligible …
located, early-stage NSCLC receiving stereotactic body radiation therapy. Methods Eligible …